Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration.

José AguarelesJuan Paraíso-LunaBelén PalomaresRaquel Bajo-GrañerasCarmen NavarreteAndrea Ruiz-CalvoDaniel García-RincónElena García-TaboadaManuel GuzmánEduardo MuñozIsmael Galve-Roperh
Published in: Translational neurodegeneration (2019)
The cannabigerol derivative VCE-003.2 improves subventricular zone-derived neurogenesis in response to mutant huntingtin-induced neurodegeneration, and is neuroprotective by oral administration.